ArticleBMC cancer2022

Daily irradiation versus irradiation at two- to three-day intervals in stereotactic radiotherapy for patients with 1-5 brain metastases: study protocol for a multicenter open-label randomized phase II trial.

Natsuo Tomita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.